News – September 19, 2008

BioAccess announces expansion of Bone Marrow Collection Kit product line to worldwide distribution

BioAccess has entered into a manufacturing agreement with a European company to produce its Bone Marrow Collection System for distribution outside the United States. BioAccess currently supplies the U.S. market with its marrow collection product, and this agreement positions the Company to serve the global bone marrow transplant market by December 2008.

The BioAccess Bone Marrow Harvest System has been recognized as a Safety Device by: CalOSHA, Frontline Healthcare Workers Safety Foundation, International Healthcare Worker Safety Center.

The Bone Marrow Collection Kit (MH-2150) incorporates several design features that allow bone marrow harvesting, bone marrow collection and bone marrow filtration to occur while eliminating steps such as spraying of a blood product. Predicate and competitive devices require the healthcare worker to spray the bone marrow during the bone marrow collection.

The BioAccess intellectual property pertaining to surgical drills, surgical power tools, bone marrow collection, and medical packaging continues to grow. This document contains forward-looking statements, including without limitation, statements concerning planned product development objectives, potential product applications, and potential advantages of BioAccess products or planned products. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties. Actual results to differ materially from the statements contained herein. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. BioAccess undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events. BioAccess is a privately owned medical device company incorporated in Delaware. Nothing on this page or site should be construed as an offer or solicitation to buy or sell any specific products or securities.